TearLab® Osmolarity System for diagnosing dry eye

Expert Review of Molecular Diagnostics

Volumn 13, Issue 2, 2013, Pages 119-129

  Versura, Piera ^a   Campos, Emilio C ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

clinical application; diagnostic performance; dry eye; lab on a chip technology; tear osmolarity

Indexed keywords

HLA DR ANTIGEN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC EQUIPMENT; DRY EYE; ENVIRONMENTAL STRESS; FREEZING; HUMAN; IMPEDANCE; KERATOMILEUSIS; LACRIMAL FLUID; NONHUMAN; OSMOLALITY; PATIENT POSITIONING; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TEAR OSMOLALITY;

DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DRY EYE SYNDROMES; HUMANS; OSMOLAR CONCENTRATION; TEARS;

EID: 84874920262     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.12.142     Document Type: Article

References (90)

1. The Epidemiology of Dry Eye Disease. In: 2007 Report of the International Dry Eye WorkShop (DEWS). Ocul. Surf. 5, 93-107 (2007).
2. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am. J. Ophthalmol. 136(2), 318-326 (2003).
3. Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am. J. Clin. Nutr. 82(4), 887-893 (2005).
4. Hovanesian JA, Shah SS, Maloney RK. Symptoms of dry eye and recurrent erosion syndrome after refractive surgery. J. Cataract Refract. Surg. 27(4), 577-584 (2001).
5. Sommer A. Vitamin A deficiency and the global response. Forum Nutr. 56, 33-35 (2003).
6. Zegans ME, Anninger W, Chapman C, Gordon SR. Ocular manifestations of hepatitis C virus infection. Curr. Opin. Ophthalmol. 13(6), 423-427 (2002).
7. [No authors listed]. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf. 5, 75-92 (2007).
8. Yu J, Asche CV, Fairchild CJ. The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea 30(4), 379-387 (2011).
9. Ridder WH 3rd, Tomlinson A, Huang JF, Li J. Impaired visual performance in patients with dry eye. Ocul. Surf. 9(1), 42-55 (2011).
10. Friedman NJ. Impact of dry eye disease and treatment on quality of life. Curr. Opin. Ophthalmol. 21(4), 310-316 (2010).
11. Sullivan DA, Hammitt KM, Schaumberg DA et al. Report of the TFOS/ARVO Symposium on global treatments for dry eye disease: an unmet need. Ocul. Surf. 10(2), 108-116 (2012).
12. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 17(6), 584-589 (1998).
13. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J. 21(4), 221-232 (1995).
14. Behrens A, Doyle JJ, Stern L et al.; Dysfunctional tear syndrome study group. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 25(8), 900-907 (2006).
15. Murube J. Tear osmolarity. Ocul. Surf. 4(2), 62-73 (2006).
16. Farris RL, Stuchell RN, Mandel ID. Tear osmolarity variation in the dry eye. Trans. Am. Ophthalmol. Soc. 84, 250-268 (1986).
17. Gilbard JP. Human tear film electrolyte concentrations in health and dry-eye disease. Int. Ophthalmol. Clin. 34(1), 27-36 (1994).
18. Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest. Ophthalmol. Vis. Sci. 47(10), 4309-4315 (2006).
19. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr. Eye Res. 19(3), 201-211 (1999).
20. Tsubota K, Fujihara T, Saito K, Takeuchi T. Conjunctival epithelium expression of HLA-DR in dry eye patients. Ophthalmologica 213(1), 16-19 (1999).
21. Li DQ, Chen Z, Song XJ, Luo L, Pflugfelder SC. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 45(12), 4302-4311 (2004).
22. Li DQ, Luo L, Chen Z, Kim HS, Song XJ, Pflugfelder SC. JNK and ERK MAP kinases mediate induction of IL-1β, TNF-α and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp. Eye Res. 82(4), 588-596 (2006).
23. Versura P, Profazio V, Schiavi C, Campos EC. Hyperosmolar stress upregulates HLA-DR expression in human conjunctival epithelium in dry eye patients and in vitro models. Invest. Ophthalmol. Vis. Sci. 52(8), 5488-5496 (2011).
24. Enríquez-de-Salamanca A, Castellanos E, Stern ME et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol. Vis. 16, 862-873 (2010).
25. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest. Ophthalmol. Vis. Sci. 45(12), 4293-4301 (2004).
26. Pflugfelder SC, de Paiva CS, Li DQ, Stern ME. Epithelial-immune cell interaction in dry eye. Cornea 27(Suppl. 1), S9-S11 (2008).
27. Corrales RM, Stern ME, De Paiva CS, Welch J, Li DQ, Pflugfelder SC. Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. Invest. Ophthalmol. Vis. Sci. 47(8), 3293-3302 (2006).
28. Yeh S, Song XJ, Farley W, Li DQ, Stern ME, Pflugfelder SC. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest. Ophthalmol. Vis. Sci. 44(1), 124-129 (2003).
29. Luo L, Li DQ, Pflugfelder SC. Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways. Cornea 26(4), 452-460 (2007).
30. Gilbard JP, Rossi SR, Gray KL, Hanninen LA, Kenyon KR. Tear film osmolarity and ocular surface disease in two rabbit models for keratoconjunctivitis sicca. Invest. Ophthalmol. Vis. Sci. 29(3), 374-378 (1988).
31. Liu H, Begley C, Chen M et al. A link between tear instability and hyperosmolarity in dry eye. Invest. Ophthalmol. Vis. Sci. 50(8), 3671-3679 (2009).
32. Bron AJ, Yokoi N, Gafney E, Tiffany JM. Predicted phenotypes of dry eye: proposed consequences of its natural history. Ocul. Surf. 7(2), 78-92 (2009).
33. Caffery B, Joyce E, Heynen ML et al. MUC16 expression in Sjogren's syndrome, KCS, and control subjects. Mol. Vis. 14, 2547-2555 (2008).
34. [No authors listed]. Methodologies to diagnose and monitor dry eye disease: report of the International Dry Eye WorkShop (DEWS). Ocul. Surf. 5, 108-152 (2007).
35. Latkany R. Dry eyes: etiology and management. Curr. Opin. Ophthalmol. 19(4), 287-291 (2008).
36. McGinnigle S, Naroo SA, Eperjesi F. Evaluation of dry eye. Surv. Ophthalmol. 57(4), 293-316 (2012).
37. Sullivan BD, Whitmer D, Nichols KK et al. An objective approach to dry eye disease severity. Invest. Ophthalmol. Vis. Sci. 51(12), 6125-6130 (2010).
38. Abelson MB, Ousler GW 3rd, Nally LA, Welch D, Krenzer K. Alternative reference values for tear film break up time in normal and dry eye populations. Adv. Exp. Med. Biol. 506(Pt B), 1121-1125 (2002).
39. Versura P, Frigato M, Mulé R, Malavolta N, Campos EC. A proposal of new ocular items in Sjögren's syndrome classification criteria. Clin. Exp. Rheumatol. 24(5), 567-572 (2006).
40. Enríquez-de-Salamanca A, Bonini S, Calonge M. Molecular and cellular biomarkers in dry eye disease and ocular allergy. Curr. Opin. Allergy Clin. Immunol. 12, 523-533 (2012).
41. Kelleher Davis R, Sullivan DA, Argueso P. Characteristics of mucin-type O-glycans in marine mammal tears. Invest. Ophthalmol. Vis. Sci. 51, E-Abstract 4163 (2010).
42. Young NM, Dawson WW. A viscous ocular secretion streams from the eyes of bottlenose dolphins Marine. Mammals Sci. 8, 57-68 (1992).
43. Balik J. The lacrimal fluid in keratoconjunctivitis sicca; a quantitative and qualitative investigation. Am. J. Ophthalmol. 35(6), 1773-1782 (1952).
44. Gilbard JP, Farris RL. Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca. Arch. Ophthalmol. 97(9), 1642-1646 (1979).
45. Farris RL. Tear osmolarity -a new gold standard? Adv. Exp. Med. Biol. 350, 495-503 (1994).
46. Mishima S, Kubota Z, Farris RL. The tear flow dynamics in normal and in keratoconjunctivitis sicca cases. XXI Concilium Ophthalmologicum (Mexico 1970). Amsterdam:Excerpta Medica. Part II, 1801-1805 (1971).
47. Benjamin WJ, Hill RM. Human tears: osmotic characteristics. Invest. Ophthalmol. Vis. Sci. 24(12), 1624-1626 (1983).
48. Nelson JD, Wright JC. Tear film osmolality determination: an evaluation of potential errors in measurement. Curr. Eye Res. 5(9), 677-681 (1986).
49. Gilbard JP, Farris RL, Santamaria J 2nd. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch. Ophthalmol. 96(4), 677-681 (1978).
50. Bron AJ, Tiffany JM, Yokoi N, Gouveia SM. Using osmolarity to diagnose dry eye: a compartmental hypothesis and review of our assumptions. Adv. Exp. Med. Biol. 506(Pt B), 1087-1095 (2002).
51. Saleh GM, Hussain B, Woodruff SA, Sharma A, Litwin AS. Tear film osmolarity in epiphora. Ophthal. Plast. Reconstr. Surg. 28(5), 338-340 (2012).
52. Wolkoff P, Kärcher T, Mayer H. Problems of the 'outer eyes' in the office environment: an ergophthalmologic approach. J. Occup. Environ. Med. 54(5), 621-631 (2012).
53. Bron AJ, Yokoi N, Gaffney EA, Tiffany JM. A solute gradient in the tear meniscus. II. Implications for lid margin disease, including meibomian gland dysfunction. Ocul. Surf. 9(2), 92-97 (2011).
54. Khanal S, Tomlinson A, McFadyen A, Diaper C, Ramaesh K. Dry eye diagnosis. Invest. Ophthalmol. Vis. Sci. 49(4), 1407-1414 (2008).
55. Koh S, Tung C, Kottaiyan R, Zavislan J, Yoon G, Aquavella J. Effect of airflow exposure on the tear meniscus. J. Ophthalmol. 2012, 983182 (2012).
56. Oncel BA, Pinarci E, Akova YA. Diurnal variation of the tear osmolarity in normal subjects measured by a new microchip system. Eur. J. Ophthalmol. 22(Suppl. 7), S1-S4 (2012).
57. Khanal S, Millar TJ. Barriers to clinical uptake of tear osmolarity measurements. Br. J. Ophthalmol. 96(3), 341-344 (2012).
58. Terry JE, Hill RM. Human tear osmotic pressure: diurnal variations and the closed eye. Arch. Ophthalmol. 96(1), 120-122 (1978).
59. Sullivan BD, Crews LA, Sönmez B et al. Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management. Cornea 31(9), 1000-1008 (2012).
60. Eperjesi F, Aujla M, Bartlett H. Reproducibility and repeatability of the OcuSense TearLab™ osmometer. Graefes Arch. Clin. Exp. Ophthalmol. 250(8), 1201-1205 (2012).
61. Versura P, Profazio V, Campos EC. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. Curr. Eye Res. 35(7), 553-564 (2010).
62. Tomlinson A, McCann LC, Pearce EI. Comparison of human tear film osmolarity measured by electrical impedance and freezing point depression techniques. Cornea 29(9), 1036-1041 (2010).
63. Lemp MA, Bron AJ, Baudouin C et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am. J. Ophthalmol. 151(5), 792-798.e1 (2011).
64. Utine CA, Biçakçigil M, Yavuz S, Çiftçi F. Tear osmolarity measurements in dry eye related to primary Sjögren's syndrome. Curr. Eye Res. 36(8), 683-690 (2011).
65. Jacobi C, Jacobi A, Kruse FE, Cursiefen C. Tear film osmolarity measurements in dry eye disease using electrical impedance technology. Cornea 30(12), 1289-1292 (2011).
66. Suzuki M, Massingale ML, Ye F et al. Tear osmolarity as a biomarker for dry eye disease severity. Invest. Ophthalmol. Vis. Sci. 51(9), 4557-4561 (2010).
67. Julio G, Lluch S, Cardona G, Fornieles A, Merindano D. Item by item analysis strategy of the relationship between symptoms and signs in early dry eye. Curr. Eye Res. 37(5), 357-364 (2012).
68. Messmer EM, Bulgen M, Kampik A. Hyperosmolarity of the tear film in dry eye syndrome. Dev. Ophthalmol. 45, 129-138 (2010).
69. Sullivan BD, Crews LA, Messmer EM et al. Correlation of commonly used clinical tests in the management of dry eye disease. Investigative Ophthalmology and Visual Science; Association for Research in Vision and Ophthalmology Abstract 550/A18 (2012).
70. Szalai E, Berta A, Szekanecz Z, Szûcs G, Módis L Jr. Evaluation of tear osmolarity in non-Sjögren and Sjögren syndrome dry eye patients with the TearLab system. Cornea 31(8), 867-871 (2012).
71. VanDerMeid KR, Su SP, Ward KW, Zhang JZ. Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests. Invest. Ophthalmol. Vis. Sci. 53(3), 1512-1518 (2012).
72. Moore JE, Vasey GT, Dartt DA et al. Effect of tear hyperosmolarity and signs of clinical ocular surface pathology upon conjunctival goblet cell function in the human ocular surface. Invest. Ophthalmol. Vis. Sci. 52(9), 6174-6180 (2011).
73. Julio G, Lluch S, Pujol P, Merindano MD. Effects of tear hyperosmolarity on conjunctival cells in mild to moderate dry eye. Ophthalmic Physiol. Opt. 32(4), 317-323 (2012).
74. Benelli U, Nardi M, Posarelli C, Albert TG. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness. Cont. Lens Anterior Eye 33(2), 61-67 (2010).
75. Baudouin C, Cochener B, Pisella PJ et al. Randomized, Phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease. Eur. J. Ophthalmol. 22(5), 751-761 (2012).
76. McCann LC, Tomlinson A, Pearce EI, Papa V. Effectiveness of artificial tears in the management of evaporative dry eye. Cornea 31(1), 1-5 (2012).
77. Na KS, Kim MS. Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease. J. Ocul. Pharmacol. Ther. 28(5), 479-483 (2012).
78. Versura P, Profazio V, Buzzi M et al. Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye. Cornea doi:10.1097/ ICO.0b013e3182580762 (2012) (Epub ahead of print).
79. Chen SP, Massaro-Giordano G, Pistilli M, Schreiber CA, Bunya VY. Tear osmolarity and dry eye symptoms in women using oral contraception and contact lenses. Cornea doi:10.1097/ICO.0b013e3182662390 (2012) (Epub ahead of print).
80. Sarac O, Gurdal C, Bostanci-Ceran B, Can I. Comparison of tear osmolarity and ocular comfort between daily disposable contact lenses: hilafilcon B hydrogel versus narafilcon A silicone hydrogel. Int. Ophthalmol. 32(3), 229-233 (2012).
81. Kojima T, Matsumoto Y, Ibrahim OM et al. Effect of controlled adverse chamber environment exposure on tear functions in silicon hydrogel and hydrogel soft contact lens wearers. Invest. Ophthalmol. Vis. Sci. 52(12), 8811-8817 (2011).
82. Dooley I, D'Arcy F, O'Keefe M. Comparison of dry-eye disease severity after laser in situ keratomileusis and laser-assisted subepithelial keratectomy. J. Cataract Refract. Surg. 38(6), 1058-1064 (2012).
83. Cho KJ, Mok JW, Choi MY, Kim JY, Joo CK. Changes in corneal sensation and ocular surface in patients with asymmetrical keratoconus. Cornea 32(2), 205-210 (2013).
84. Labbé A, Terry O, Brasnu E, Van Went C, Baudouin C. Tear film osmolarity in patients treated for glaucoma or ocular hypertension. Cornea 31(9), 994-999 (2012).
85. Januleviciene I, Derkac I, Grybauskiene L, Paulauskaite R, Gromnickaite R, Kuzmiene L. Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma. Clin. Ophthalmol. 6, 103-109 (2012).
86. Fortes MB, Diment BC, Di Felice U et al. Tear fluid osmolarity as a potential marker of hydration status. Med. Sci. Sports Exerc. 43(8), 1590-1597 (2011).
87. Advanced® Micro-Osmometer. www.aicompanies.com
88. Otago Osmometer. www.otago-osmometers.com
89. Wescor vapor pressure osmometer. www.wescor.com
90. TearLab® Osmolarity System. www.tearlab.com